India is the largest global supplier of generic drugs and the Indian pharmaceutical industry is growing rapidly, projected to reach $65 billion by 2024 and $130 billion by 2030. Growth is driven by increasing R&D investments, government initiatives, and rising domestic healthcare demand  Foreign Institutional Investors (FIIs) increasing their holding stake in certain companies indicate … Continue reading Pharma stocks in which FIIs increased their stake by up to 3.45% in Q1